HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Bhattacharjee Selected Research

3- (2,3- dihydro- 5- benzofuranyl)- 1,2,3,4- tetrahydro- 2- (5- (2- pyridinyl)- 2- pyrimidinyl)- 9H- pyrrolo(3,4- b)quinolin- 9- one

9/2006JNJ-10280205 and JNJ-10287069: Novel PDE5 inhibitors as clinical candidates for erectile dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Bhattacharjee Research Topics

Disease

3Infections
01/2009 - 12/2007
2Alzheimer Disease (Alzheimer's Disease)
11/2011 - 01/2011
2Necrosis
04/2008 - 12/2007
1IGA Glomerulonephritis (IGA Nephropathy)
01/2022
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2022
1Pain (Aches)
01/2022
1Amyloidosis
01/2022
1Body Weight (Weight, Body)
01/2022
1Fever (Fevers)
01/2022
1Glomerulonephritis
01/2022
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2022
1Lupus Nephritis
01/2022
1Nephritis
01/2022
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2022
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2017
1Parkinson Disease (Parkinson's Disease)
01/2017
1Nevus (Nevi)
04/2013
1Melanoma (Melanoma, Malignant)
04/2013
1Peroneal Neuropathies
02/2013
1Nervous System Diseases (Neurological Disorders)
11/2011
1Visceral Leishmaniasis (Kala Azar)
04/2008
1Leishmaniasis
12/2007
1Erectile Dysfunction
09/2006
1Sepsis (Septicemia)
11/2001
1Inflammation (Inflammations)
11/2001

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
04/2008 - 11/2001
2Messenger RNA (mRNA)IBA
04/2008 - 12/2007
2CC ChemokinesIBA
04/2008 - 12/2007
2CytokinesIBA
04/2008 - 12/2007
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Dopamine D3 ReceptorsIBA
01/2017
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
04/2013
1MicroRNAs (MicroRNA)IBA
11/2011
1Retinaldehyde (Retinal)IBA
01/2011
1SmokeIBA
01/2009
1lipoarabinomannan (LAM)IBA
04/2008
1Interleukin-12 (IL 12)IBA
04/2008
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2008
1CCR5 Receptors (CCR5 Receptor)IBA
04/2008
1Small Interfering RNA (siRNA)IBA
04/2008
1ChemokinesIBA
12/2007
1Protein Kinase CIBA
12/2007
1InterferonsIBA
12/2007
1Free RadicalsIBA
12/2007
1Interleukin-10 (Interleukin 10)IBA
12/2007
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
12/2007
1Chemotactic FactorsIBA
12/2007
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2007
1Interleukin-12 Subunit p40IBA
12/2007
1Phosphodiesterase 5 InhibitorsIBA
09/2006
13- (2,3- dihydro- 5- benzofuranyl)- 1,2,3,4- tetrahydro- 2- (5- (2- pyridinyl)- 2- pyrimidinyl)- 9H- pyrrolo(3,4- b)quinolin- 9- oneIBA
09/2006
13- (2,3- dihydrobenzofuran- 5- yl)- 2- pyridin- 2- yl- 1,2,3,4- tetrahydropyrrolo(3,4- b)quinolin- 9- oneIBA
09/2006
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
09/2006
1NADPH Oxidases (NAD(P)H oxidase)IBA
11/2001
1dityrosineIBA
11/2001

Therapy/Procedure

1Intramuscular Injections
02/2013